Publication: Treatment of COVID-19 Patients during Second Wave in a Tertiary Care Center of Nepal
| creativeworkseries.issn | ISSN (Print) : 1993-2979 | ISSN (Online) : 1993-2987 | |
| dc.contributor.author | Devkota, Pragya | |
| dc.contributor.author | Bajracharya, Omi | |
| dc.contributor.author | Manandhar, Tejendra | |
| dc.contributor.author | Kafle, Sajala | |
| dc.contributor.author | Jha, Nisha | |
| dc.contributor.author | Kafle, Kumud K | |
| dc.contributor.author | Sijapati, Milesh J | |
| dc.date.accessioned | 2026-02-25T08:27:54Z | |
| dc.date.available | 2026-02-25T08:27:54Z | |
| dc.date.issued | 2022 | |
| dc.description | Pragya Devkota1, Omi Bajracharya1, Tejendra Manandhar1, Sajala Kafle1, Nisha Jha1, Kumud K Kafle1, Milesh J Sijapati2 1Department of Clinical Pharmacology and Therapeutics, KIST Medical College and Teaching Hospital, Lalitpur, Nepal 2Department of Internal Medicine, KIST Medical College and Teaching Hospital, Lalitpur, Nepal | |
| dc.description.abstract | ABSTRACT Introduction: The second wave of the COVID-19 pandemic was confirmed in Nepal in April 2021. It was caused by genetic variants of SARS-CoV2. The objective of the study was to find out severity of patients, their treatment and approximate drug cost for the treatment of COVID-19 in the second wave. Methods: In this retrospective, cross-sectional study, data of all patients who tested positive and were admitted in KIST Medical College and Teaching Hospital between April 2021 – July 2021 was collected for the study. A total of 215 patients were included. Results: Among the cases admitted, 190 (88.4%) patients were symptomatic. ICU/HDU admission was done in 113 (52.5%) cases, among which 33 (29.2%) patients received ventilator support. The patients treated in isolation unit were 102 (47.4%). Among the patients admitted, 23 (10.7%) were vaccinated. Severe cases were 80 (37%), moderate cases were 71 (33%) and mild cases were 49 (23%). Antibiotics were used in 190 (88.4%) cases. More than one antibiotics were used in 141 (65.6%) cases. Antifungals were used in 39 (18.1%) cases. Other drugs like corticosteroids were used in 185 (86%), proton-pump inhibitors in 179 (84.3%), antihistaminics in 169 (78.4%) and anticoagulants in 165 (76.7%), Vitamin C in 153 (71.2%), Vitamin D in 152 (70.7%) and zinc in 140 (65.1%) cases. The number of patients discharged after recovery was 151 (70.2%) and 41 (19.5%) patients died. The average drug cost was NPR. 3,246 in mild, 27,645 in moderate and 76,420 in severe cases. Conclusion: Majority of patients were treated in ICU/HDU. Most commonly used drugs were antibiotics, corticosteroids and anticoagulants. Mortality was high in the second wave. Keywords: Cost, COVID-19, drugs | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14572/4931 | |
| dc.language.iso | en_US | |
| dc.publisher | Institute of Medicine | |
| dc.subject | Cost | |
| dc.subject | COVID-19 | |
| dc.subject | drugs | |
| dc.title | Treatment of COVID-19 Patients during Second Wave in a Tertiary Care Center of Nepal | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.article.type | Original Article | |
| oaire.citation.endPage | 68 | |
| oaire.citation.startPage | 63 | |
| relation.isJournalIssueOfPublication | d201b633-9b20-45d8-bc85-2aeb2e7bfe12 | |
| relation.isJournalIssueOfPublication.latestForDiscovery | d201b633-9b20-45d8-bc85-2aeb2e7bfe12 | |
| relation.isJournalOfPublication | a9ba45d9-ee33-4a6b-b1fc-6626b87eec6c |